Yin, C., & Song, C. (2024). Tumor Intrinsic Immunogenicity Suppressor SETDB1 Worsens the Prognosis of Patients with Hepatocellular Carcinoma. Cells (2073-4409), 13(24), 2102. https://doi.org/10.3390/cells13242102
Chicago Style (17th ed.) CitationYin, Chang-Qing, and Chun-Qing Song. "Tumor Intrinsic Immunogenicity Suppressor SETDB1 Worsens the Prognosis of Patients with Hepatocellular Carcinoma." Cells (2073-4409) 13, no. 24 (2024): 2102. https://doi.org/10.3390/cells13242102.
MLA (9th ed.) CitationYin, Chang-Qing, and Chun-Qing Song. "Tumor Intrinsic Immunogenicity Suppressor SETDB1 Worsens the Prognosis of Patients with Hepatocellular Carcinoma." Cells (2073-4409), vol. 13, no. 24, 2024, p. 2102, https://doi.org/10.3390/cells13242102.
Warning: These citations may not always be 100% accurate.